MetLife (NYSE: MET) director granted 1,248 deferred shares as fees

Rhea-AI Filing Summary

HUBBARD ROBERT GLENN reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Robert Glenn Hubbard received a grant of 1,248 shares of common stock valued at $71.17 per share as part of non-management director compensation. This award reflects retainer fees that are paid in MetLife stock rather than cash.

The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, so the shares are credited rather than immediately delivered. Following this grant, he holds 105,878 shares of MetLife common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HUBBARD ROBERT GLENN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,248	$71.17	$89K

Holdings After Transaction: Common Stock — 105,878 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 1,248 shares Grant value per share: $71.17 per share Total shares after grant: 105,878 shares

3 metrics

Shares granted 1,248 shares Director stock grant as retainer fees

Grant value per share $71.17 per share Recorded value of common stock grant

Total shares after grant 105,878 shares Director’s direct holdings following transaction

Key Terms

non-management director compensation arrangements, retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors

3 terms

non-management director compensation arrangements financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees"

retainer fees financial

"pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock"

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUBBARD ROBERT GLENN

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		1,248	A	$71.17	105,878	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did MetLife (MET) director Robert Glenn Hubbard report in this Form 4?

Robert Glenn Hubbard reported receiving 1,248 shares of MetLife common stock as a grant tied to his director retainer fees. The shares were valued at $71.17 each and increase his directly held position to 105,878 shares.

Was the MetLife (MET) Form 4 transaction an open-market purchase or sale?

The transaction was a grant or award, not an open-market trade. Shares were issued as part of non-management director compensation, reflecting retainer fees paid in MetLife common stock rather than a discretionary market buy or sell.

How many MetLife (MET) shares does Robert Glenn Hubbard hold after this grant?

After the 1,248-share grant, Robert Glenn Hubbard holds 105,878 shares of MetLife common stock directly. This figure reflects his total direct ownership position immediately following the reported compensation-related award on the Form 4.

At what price was the MetLife (MET) director share grant recorded?

The grant of 1,248 MetLife common shares to Robert Glenn Hubbard was recorded at $71.17 per share. This price is an accounting value for the award, not necessarily a trade price from an open-market transaction or purchase.

How are MetLife (MET) non-management directors compensated in stock?

MetLife’s non-management director compensation arrangements pay a portion of director and Board Chair retainer fees in MetLife common stock. Directors can elect to defer receipt of these shares into the MetLife Deferred Compensation Plan for Non-Management Directors, as Robert Glenn Hubbard did here.

What does it mean that the MetLife (MET) director deferred receipt of shares?

Deferring receipt means the director chose not to take the shares immediately, instead crediting them under MetLife’s Deferred Compensation Plan for Non-Management Directors. This is an administrative, compensation-related decision rather than a market transaction involving buying or selling stock.